USA – Arrowhead Pharmaceuticals, a company aiming to develop drugs using RNA interference technology, has announced that it has licensed an experimental medicine for a common liver disease to GlaxoSmithKline…
Read MoreUSA – Arrowhead Pharmaceuticals, a company aiming to develop drugs using RNA interference technology, has announced that it has licensed an experimental medicine for a common liver disease to GlaxoSmithKline…
Read More